Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Trans Care In Court: DOJ Memo, Ohio Ban And Insurer Loss No Photo Available

Gianna Ferrarin

Ohio's highest court is allowing the state to enforce a law banning the use of puberty blockers and hormones for minors seeking to med... (more story)

This Week's Healthcare Earnings: Tariffs Galore No Photo Available

Yeji Jesse Lee

Tariffs were, unsurprisingly, a major theme on investor calls this past week, as around a dozen healthcare companies released their qu... (more story)

Eli Lilly Opens New Front Against Weight-Drug Compounders No Photo Available

Mark Payne

Pharma giant Eli Lilly is taking a new tack in its efforts to protect its lucrative weight-loss drugs by raising allegations that tele... (more story)